Search

everythinglearnresearchcommunity

for

Search:↓

sPLA2-IIA increases growth in hair follicle stem cells and cancer cells, suggesting it could be targeted for hair growth and cancer treatment.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.

Compounds from Etlingera alba may help treat Triple Negative Breast Cancer.

Palbociclib generally maintains or improves quality of life in advanced breast cancer patients.

Scalp cooling reduces hair loss during chemotherapy but doesn't help hair regrow after.

Scalp cooling effectively reduces hair loss in breast cancer patients undergoing chemotherapy.

HER2-targeted or hormonal therapies improve quality of life for Sudanese breast cancer patients.

c-Kit is important for heart regeneration and cancer development.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

Alopecia areata and myasthenia gravis can occur as rare symptoms of breast cancer.

Certain natural compounds called terpenes may help prevent prostate cancer.

Certain genetic markers on the Y-chromosome may influence prostate cancer risk in Iraqi males.

A new method accurately measures cell changes in breast cancer.

Inhaling medicine may reduce side effects and improve treatment for a major lung cancer type.

Melanoma occurs more on the left side of the body, unlike other skin cancers.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

Sorafenib and Platycladus orientalis leaf extract together effectively suppress cervical cancer cell growth.

TSC22D genes are key in metabolic diseases and cancer, offering potential as treatment targets.

Synthetic curcumin derivatives improve treatment for diabetes and cancer.

Using 5α-reductase inhibitors for hair loss in women doesn't increase cancer risk.

Most adverse reactions to the treatment were mild, with nausea being the most common.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

Bio-based materials like hydrogels show promise in treating skin cancer with fewer side effects, but more research is needed.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.